Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
2.
Ann Oncol ; 21(2): 255-262, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19633047

RESUMEN

BACKGROUND: The mechanism of resistance to human epidermal growth factor receptor 2 (HER2)-targeted agents has not been fully understood. We investigated the influence of PIK3CA mutations on sensitivity to HER2-targeted agents in naturally derived breast cancer cells. MATERIALS AND METHODS: We examined the effects of Calbiochem (CL)-387,785, HER2 tyrosine kinase inhibitor, and trastuzumab on cell growth and HER2 signaling in eight breast cancer cell lines showing HER2 amplification and trastuzumab-conditioned BT474 (BT474-TR). RESULTS: Four cell lines with PIK3CA mutations (E545K and H1047R) were more resistant to trastuzumab than the remaining four without mutations (mean percentage of control with 10 microg/ml trastuzumab: 58% versus 92%; P = 0.010). While PIK3CA-mutant cells were more resistant to CL-387,785 than PIK3CA-wild-type cells (mean percentage of control with 1 microM CL-387,785: 21% versus 77%; P = 0.001), CL-387,785 retained activity against BT474-TR. Growth inhibition by trastuzumab and CL-387,785 was more closely correlated with changes in phosphorylation of S6K (correlation coefficient, 0.811) than those of HER2, Akt, or ERK1/2. Growth of most HER2-amplified cells was inhibited by LY294002, regardless of PIK3CA genotype. CONCLUSIONS: PIK3CA mutations are associated with resistance to HER2-targeted agents. PI3K inhibitors are potentially effective in overcoming trastuzumab resistance caused by PIK3CA mutations. S6K phosphorylation is a possibly useful pharmacodynamic marker in HER2-targeted therapy.


Asunto(s)
Antineoplásicos/administración & dosificación , Neoplasias de la Mama/genética , Resistencia a Antineoplásicos/genética , Fosfatidilinositol 3-Quinasas/genética , Receptor ErbB-2/antagonistas & inhibidores , Receptor ErbB-2/genética , Anticuerpos Monoclonales/administración & dosificación , Anticuerpos Monoclonales/farmacología , Anticuerpos Monoclonales Humanizados , Antineoplásicos/farmacología , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/patología , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Cromonas/administración & dosificación , Cromonas/farmacología , Fosfatidilinositol 3-Quinasa Clase I , Relación Dosis-Respuesta a Droga , Sistemas de Liberación de Medicamentos , Evaluación Preclínica de Medicamentos , Activación Enzimática/genética , Femenino , Amplificación de Genes/fisiología , Humanos , Morfolinas/administración & dosificación , Morfolinas/farmacología , Mutación Missense/fisiología , Fosfatidilinositol 3-Quinasas/fisiología , Fosforilación/efectos de los fármacos , Fosforilación/genética , Inhibidores de Proteínas Quinasas/administración & dosificación , Inhibidores de Proteínas Quinasas/farmacología , Receptor ErbB-2/metabolismo , Proteínas Quinasas S6 Ribosómicas/metabolismo , Trastuzumab
3.
Fresenius J Anal Chem ; 370(7): 855-9, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11569864

RESUMEN

A direct method for determination of silicon in powdered high-purity aluminium oxide samples, by slurry sampling with in situ fusion graphite-furnace atomic-absorption spectrometry (GF-AAS), has been established. A slurry sample was prepared by 10-min ultrasonication of a powdered sample in an aqueous solution containing both sodium carbonate and boric acid as a mixed flux. An appropriate portion of the slurry was introduced into a pyrolytic graphite furnace equipped with a platform. Silicon compounds to be determined and aluminium oxide were fused by the in situ fusion process with the flux in the furnace under optimized heating conditions, and the silicon absorbance was then measured directly. The calibration curve was prepared by use of a silicon standard solution containing the same concentration of the flux as the slurry sample. The accuracy of the proposed method was confirmed by analysis of certified reference materials. The proposed method gave statistically accurate values at the 95% confidence level. The detection limit was 3.3 microg g(-1) in solid samples, when 300 mg/20 mL slurry was prepared and a 10 microL portion of the slurry was measured. The precision of the determination (RSD for more than four separate determinations) was 14% and 2%, respectively, for levels of 10 and 100 microg g(-1) silicon in aluminium oxide.


Asunto(s)
Óxido de Aluminio/análisis , Silicio/análisis , Espectrofotometría Atómica/métodos , Polvos/química , Control de Calidad , Temperatura
5.
Chem Pharm Bull (Tokyo) ; 48(5): 657-9, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10823702

RESUMEN

Structures of three new sesquiterpene lactones 1-3, isolated from the pericarps of Illicium merrillianum, have been assigned as 14-O-benzoylfloridanolide, 2,10-epoxy-3-dehydroxypseudoanisatin and 7-O-methylpseudomajucin on the basis of spectroscopic data and chemical transformation. The structure of 2, having an ether linkage between C-2 and C-10, has been confirmed by X-ray crystallographic analysis.


Asunto(s)
Lactonas/aislamiento & purificación , Plantas Medicinales/química , Sesquiterpenos/aislamiento & purificación , China , Cristalografía por Rayos X , Frutas/química , Espectroscopía de Resonancia Magnética , Conformación Molecular , Espectrometría de Masa Bombardeada por Átomos Veloces , Espectrofotometría Infrarroja
6.
Chem Pharm Bull (Tokyo) ; 48(2): 301-3, 2000 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10705527

RESUMEN

Two new azadirachtin-type limonoids, 1-methacrylyl-3-acetyl-11-methoxymeliacarpinin (1) and 1-(2-methylpropanoyl)-3-acetyl-11-methoxymeliacarpinin (2), together with the known compounds, meliacarpinin D (3), melianin B (4) and 2 beta,3 beta-dihydroxy-5 alpha-pregn-17(20)-(Z)-en-16-one (5), were isolated from the roots of Melia azedarach. The structures of 1 and 2 were elucidated by analysis of spectroscopic data and comparison of their NMR data with those of 3. Compounds 1 and 5 exhibited significant activity in the brine shrimp lethality test (BST).


Asunto(s)
Antineoplásicos Fitogénicos/aislamiento & purificación , Limoninas , Plantas Medicinales/química , Triterpenos/aislamiento & purificación , Animales , Antineoplásicos Fitogénicos/farmacología , Artemia , Espectroscopía de Resonancia Magnética , Conformación Molecular , Raíces de Plantas/química , Triterpenos/farmacología
7.
J Dermatol Sci ; 23(1): 22-6, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10699761

RESUMEN

Dye lasers are useful for treating pigmented skin lesions, but their equipment is expensive and bulky. A simple and cheap phototherapy would be acceptable to dermatologists for treating pigmented skin lesions such as nevus of Ota. We investigated as a pilot study whether dermal injection of riboflavin and exposure to near-ultraviolet/visible radiation (ribophototherapy) decreases the dermal pigment of blue nevi which are recalcitrant to laser therapy. The therapeutic efficacy was assessed by comparison of the amount of dermal pigment in hematoxylin-eosin specimens taken before and after treatment. Pigmentation of the nevus became faint to the depth of 1 mm with little noticeable epidermal change after 21 treatments. At the deeper dermis somewhere between 3 and 4 mm from the epidermis, ballooning degeneration of the dermal cells was observed in hematoxylin-eosin specimens. Ribophototherapy is hopeful for treating pigmented skin lesions.


Asunto(s)
Nevo Azul/tratamiento farmacológico , Fotoquimioterapia/métodos , Fármacos Fotosensibilizantes/administración & dosificación , Riboflavina/administración & dosificación , Neoplasias Cutáneas/tratamiento farmacológico , Adulto , Humanos , Inyecciones Intradérmicas , Masculino , Microscopía Electrónica , Nevo Azul/patología , Neoplasias Cutáneas/patología , Pigmentación de la Piel/efectos de los fármacos , Pigmentación de la Piel/efectos de la radiación , Terapia Ultravioleta
8.
Kyobu Geka ; 52(9): 747-50, 1999 Aug.
Artículo en Japonés | MEDLINE | ID: mdl-10453165

RESUMEN

The efficacy of predonation of autologous blood in reducing the use homologous blood during open heart surgery was investigated. Between January 1997, and February 1998, predonation and transfusion was studied in 100 consecutive open heart operations (CABG, 77; valve surgery, 17; ASD, 5; myxoma, 1). The guidelines for autologous predonation were as follows: an age < 70 years, a weight > 40 kg and a hemoglobin > 12 g/dl. Patients in NYHA class IV or undergoing emergency operation were excluded. The blood loss during operation ranged from 195 to 1,850 ml (mean; 670 ml), being from 305 to 1,850 ml (723 ml) for CABG, from 260 to 1,020 ml (493.5 ml) for valve surgery and from 195 to 570 ml (342 ml) for ASD. The blood loss was not significantly dependent on sex or age and did not differ elective and emergent operations. Only 36.6% of patients with autologous predonation needed homologous transfusion versus 63.4% of those without predonation. Homologous transfusion was done in only 5% of the those with predonation of 800 ml versus 69% at 400 ml and 71% at 200 ml. In conclusion, autologous blood transfusion is effective for reducing the homologous blood requirement. It also seems that predonation of 800 ml may be sufficient to allow open heart surgery without blood transfusion.


Asunto(s)
Transfusión de Sangre Autóloga , Procedimientos Quirúrgicos Cardíacos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Transfusión Sanguínea , Transfusión de Sangre Autóloga/métodos , Femenino , Humanos , Masculino , Persona de Mediana Edad
9.
Chem Pharm Bull (Tokyo) ; 45(5): 947-9, 1997 May.
Artículo en Inglés | MEDLINE | ID: mdl-9178529

RESUMEN

Garsubellin A (1), a novel polyprenylated phloroglucin derivative, has been isolated from the wood of Garcinia subelliptica and its structure has been elucidated by spectroscopic analyses. Compound 1 could increase the ChAT activity at 10 microM in P10 rat septal neuron cultures.


Asunto(s)
Encéfalo/enzimología , Colina O-Acetiltransferasa/metabolismo , Neuronas/enzimología , Plantas Medicinales/química , Terpenos/farmacología , Animales , Encéfalo/citología , Encéfalo/efectos de los fármacos , Espectroscopía de Resonancia Magnética , Neuronas/efectos de los fármacos , Ratas , Estimulación Química , Terpenos/aislamiento & purificación
11.
Biochem J ; 305 ( Pt 1): 81-5, 1995 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-7826357

RESUMEN

A cDNA clone encoding a protein 69% identical in amino acid sequence with that of the Na/P(i) co-transporter NaP(i)-1 was isolated from a human kidney cDNA library. The DNA sequence was identical with that of NPT-1 cDNA published by Chong, Kristjansson, Zoghbi and Hughe (1993) (Genomics, 18, 355-359). In the present study, we have characterized the function of the encoded protein and the tissue distribution of its mRNA. Injection of RNA transcribed from NPT-1 into Xenopus oocytes resulted in expression of Na/P(i) co-transport activity showing a high affinity for P(i) transport (Km 0.29 mM). Kinetic characterization ([P(i)], [Na+]) demonstrated that the expressed transport activity has properties similar to those displayed by oocytes injected with human kidney poly(A)+ RNA. Northern blotting demonstrated that NPT-1 mRNA is expressed in renal cortex, liver and brain but not in other tissues. Hybrid depletion with antisense oligonucleotides to NaP(i)-3 and NPT-1 completely inhibited poly(A)+ RNA-induced Na(+)-dependent P(i) uptake in oocytes. These findings indicate that two high-affinity Na/P(i) cotransporters (NaP(i)-3 and NPT-1) are present in human kidney cortex.


Asunto(s)
Proteínas Portadoras/genética , Proteínas Portadoras/fisiología , ADN Complementario/genética , ADN Complementario/fisiología , Corteza Renal/química , Corteza Renal/fisiología , Simportadores , Animales , Secuencia de Bases , Northern Blotting , Clonación Molecular , ADN Complementario/aislamiento & purificación , Femenino , Biblioteca Genómica , Humanos , Cinética , Datos de Secuencia Molecular , Oligonucleótidos Antisentido/farmacología , Fosfatos/farmacocinética , Reacción en Cadena de la Polimerasa , ARN Complementario/análisis , ARN Complementario/genética , ARN Mensajero/análisis , ARN Mensajero/efectos de los fármacos , ARN Mensajero/genética , Conejos , Sodio/farmacocinética , Sodio/farmacología , Proteínas Cotransportadoras de Sodio-Fosfato , Proteínas Cotransportadoras de Sodio-Fosfato de Tipo I , Xenopus laevis
12.
Pharmacol Biochem Behav ; 16(2): 311-4, 1982 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-7200239

RESUMEN

Circadian fluctuation has been reported to exist to the effects of haloperidol after acute administration. In an attempt to clarify the viability of chronotherapy with haloperidol, the antiapomorphine effect of haloperidol after chronic administration was investigated in the present paper. Haloperidol was administered once daily at the same time for 21 consecutive days to rats which were kept under 12 hr lighting conditions with light onset at 19:30. Then the chronology of the antiapomorphine effect was investigated. The antiapomorphine effect was significantly stronger in the group treated at 19:30 than that treated at 13:30. These data agreed with the results found after the acute administration of the drug. After chronic administration, no difference was found in the plasma and brain level of haloperidol due to the time of administration. These experimental results seem to suggest that a circadian rhythm in the brain susceptibility to haloperidol exists even during chronic administration.


Asunto(s)
Encéfalo/efectos de los fármacos , Ritmo Circadiano , Haloperidol/farmacología , Animales , Apomorfina/antagonistas & inhibidores , Encéfalo/metabolismo , Haloperidol/metabolismo , Humanos , Masculino , Ratas , Ratas Endogámicas , Conducta Estereotipada/efectos de los fármacos , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA